反応式
C([O-])([O-])=O.[Cs+].[Cs+].OC1C=CC=C2C=1N=CC=C2.[CH3:18][C:19]1[C:20](=[O:26])[NH:21][CH:22]=[C:23]([CH3:25])[CH:24]=1.Br[C:28]1[S:32][C:31]([C:33]2[CH:38]=[CH:37][C:36]([O:39][CH2:40][CH3:41])=[CH:35][CH:34]=2)=[N:30][CH:29]=1>CS(C)=O.[Cu]I>[CH2:40]([O:39][C:36]1[CH:35]=[CH:34][C:33]([C:31]2[S:32][C:28]([N:21]3[CH:22]=[C:23]([CH3:25])[CH:24]=[C:19]([CH3:18])[C:20]3=[O:26])=[CH:29][N:30]=2)=[CH:38][CH:37]=1)[CH3:41]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of CuI (0.038 g, 0.20 mmol), Cs2CO3 (0.98 g, 3.00 mmol) and 8-hydroxyquinoline ligand (0.029 g, 0.20 mmol) in DMSO (2 mL) was stirred at rt for 30 min under N2. Then to the reaction mixture was added a solution of 3,5-dimethylpyridin-2(1H)-one (0.30 g, 2.40 mmol) and 5-bromo-2-(4-ethoxyphenyl)thiazole (0.57 g, 2.00 mmol) in DMSO (2 mL) via syringe. The reaction mixture was heated at 130° C. for 12 h, then cooled to rt and filtered. The filtrate was diluted with H2O (10 mL) and extracted with CH2Cl2 (20 mL×3). The combined organic phases were concentrated in vacuo. The residue was purified by a silica gel column chromatography (PE/EtOAc (V/V)=1:10) to give the title compound (0.17 g, 26%). The compound was characterized by the following spectroscopic data:
後処理
- temperatureThe reaction mixture was heated at 130° C. for 12 h
- temperaturecooled to rt
- filtrationfiltered
- additionThe filtrate was diluted with H2O (10 mL)
- extractionextracted with CH2Cl2 (20 mL×3)
- concentrationThe combined organic phases were concentrated in vacuo
- customThe residue was purified by a silica gel column chromatography (PE/EtOAc (V/V)=1:10)
出典と根拠
- ORDレコード
- ord-0282cdf79cd446d2ad73ec2520a83efd
- 出典データセット
- uspto-grants-2016_09
- 特許番号
- US09434695B2
関連ノート
読み込み中…